Field Trip Health (FTRPF) Stock Price, News & Analysis

Company Overview

Field Trip Health Inc. was a mental health care company focused on developing and delivering psychedelic-assisted therapies. Through its Field Trip Health clinics, the company provided services intended to address conditions such as depression, anxiety and post-traumatic stress, including ketamine-assisted therapy, psychotherapy and related wellness programs.

The company also operated a research and drug-development division, Field Trip Discovery, which worked on psychedelic compounds and therapeutic protocols, including FT-104, a synthetic compound based on the psilocybin molecule. Its clinic operations historically served patients in Canada and the United States.

Field Trip Health was founded in 2019, with co-founder Ronan Levy serving in senior leadership roles, including chief executive officer and executive chairman during the company’s development. In 2023, the company entered creditor-protection proceedings in Canada and subsequently pursued the sale or restructuring of its assets. As a result, its historical operations and corporate status may differ substantially from those of an active operating company.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 64,700 shs
• Average Volume: 59,938 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:FTRPF
• CIK: N/A
• Web: www.fieldtriphealth.com
• Phone: 833 222 0084
• Fax: N/A
• Employees: 104
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A